AGN: Allergan plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 65,103.89
Enterprise Value ($M) 92,044.61
Book Value ($M) 61,542.00
Book Value / Share 187.74
Price / Book 1.06
NCAV ($M) -30,187.40
NCAV / Share -92.09
Price / NCAV -2.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 0.60
Current Ratio 0.71

Balance Sheet (mrq) ($M)
Current Assets 6,289.30
Assets 98,036.30
Liabilities 36,476.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -6,247.60
Net Income -5,086.20
Earnings Per Share Diluted -15.26
Earnings Per Share Basic -15.26

Cash Flow Statement (mra) ($M)
Cash From Operations 5,640.10
Cash from Investing 3,098.50
Cash from Financing 3,098.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-12 13G/A Vanguard Group Inc 7.46 1.35
2020-02-10 13G/A BlackRock Inc. 6.30 -3.07
2019-04-12 13D/A Cf Partners Capital Management Llp 9.08
2019-02-12 13G/A Wellington Management Group LLP 7.39 15.98
2019-01-22 13G/A GIC Private Ltd 4.59 -9.18
2018-02-08 13G/A Goldman Sachs Group Inc 0.70 -89.64
2017-02-06 13G/A Price T Rowe Associates Inc /md/ 2.80 -58.06
2016-02-12 13G/A FMR LLC / Fidelity 4.17
2015-03-23 13D/A Pershing Square Capital Management, L.P. 0.00
2015-02-13 13G/A Capital Research Global Investors 0.00
2014-11-20 13D/A Valeant Pharmaceuticals International, Inc. 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-05 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-11-05 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-05-07 10-Q AGN / Allergan plc 10-Q Quarterly Report 10-Q
2019-05-07 10-Q AGN / Allergan plc 10-Q Quarterly Report 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 107,729 3,059,300 3.52
2020-02-13 177,340 2,450,400 7.24
2020-02-12 102,884 2,591,000 3.97
2020-02-11 99,600 2,422,100 4.11

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ALR – Alere Inc. BHC – BauschHealth?Companies?Inc.


Financial data and stock pages provided by
Fintel.io